Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Retinoblastoma × Observation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Endometrial Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Leukemia 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Retinoblastoma 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1

Interventions

Vincristine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 trioctyl phosphine oxide 1 pembrolizumab 1 pegfilgrastim 1 Topotecan 1 Thiotepa 1 Surveys and Questionnaires 1 Observation 1 Mesna 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Eye Enucleation 1 Doxorubicin 1 Cytapheresis 1 Cryotherapy 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡